#IDMastodon #pedslD The #SARSCoV2 #mRNAvaccines (BNT162b2) & (mRNA-1273) are approved by EMEA & @fda_drug_info for use in children from 6 mths of age. These vaccines offer excellent protection from severe disease & #Longcovid in children & adults that also protect children from MIS-C .At a comparable dose (100 μg), children aged 6–11 years elicit higher titre #antibody responses to the mRNA-1273 vaccine vs adults and with stronger Fc binding capacity.

#IDMastodon #Epidemiology #pedslD Persistent clinical features beyond 3 mth among children and adolescents with proven #COVID19 are common ,the symptom spectrum is wide in #LongCovid & #LongCovidKids ,Female gender was found to be associated with a higher risk of developing certain LC symptoms, ie, sleep disturbance ,headache
https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060351/192816/A-Systematic-Review-of-Persistent-Clinical?autologincheck